CARDIFF ONCOLOGY INC (CRDF) Stock Analyst Earnings Estimates
NASDAQ:CRDF - Nasdaq - US14147L1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 390K 8.33% | 488K 25.13% | 683K 39.96% | 420.373K -38.45% | 326.278K -22.38% | 122.4K -62.49% | 135.997K 11.11% | 111.29M 81,732.93% | 372.3M 234.53% | 969M 160.27% | 964.92M -0.42% | |
| EBITDA YoY % growth | -39.66M -39.60% | -45.014M -13.50% | -48.247M -7.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.9M -38.25% | -45.412M -13.81% | -48.651M -7.13% | -59.347M -21.98% | -72.55M -22.25% | -98.466M -35.72% | -167.487M -70.10% | -134.16M 19.90% | 12.036M 108.97% | 639.54M 5,213.56% | 564.06M -11.80% | |
| Operating Margin | -10,230.77% | -9,305.74% | -7,123.13% | -14,117.67% | -22,235.53% | -80,446.33% | -123,155.58% | -120.55% | 3.23% | 66.00% | 58.46% | |
| EPS YoY % growth | -0.89 -25.35% | -0.93 -4.49% | -0.95 -2.15% | -0.81 14.64% | -0.95 -16.62% | -1.21 -28.10% | -2.02 -66.71% | -2.43 -20.20% | N/A | N/A | 1.74 |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 24.48% | -0.20 19.93% | -0.21 3.80% | -0.23 -13.22% | -0.30 -50.65% | -0.31 -56.26% | -0.32 -52.61% | -0.42 -84.68% | -0.41 -37.93% | -0.43 -36.96% |
| Revenue Q2Q % growth | 108.375K -33.51% | 108.375K -34.32% | 108.375K -28.23% | 63.75K -41.51% | 51K -52.94% | 51K -52.94% | 51K -52.94% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.402M -14.80% | -14.698M -16.65% | -15.942M -26.81% | -15.368M -6.86% | -17.289M -20.05% | -18.207M -23.87% | -19.023M -19.33% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.20 9.09% | -0.19 | -0.01 | -5.25% |
| Q4 2024 Q2Q % growth | -0.22 -4.76% | -0.25 | 0.03 | 10.75% |
| Q3 2024 Q2Q % growth | -0.25 -13.64% | -0.28 | 0.03 | 9.22% |
| Q2 2024 Q2Q % growth | -0.26 -4.00% | -0.25 | -0.01 | -2.99% |
| Q1 2024 Q2Q % growth | -0.22 12.00% | -0.25 | 0.03 | 12.85% |
| Q4 2023 Q2Q % growth | -0.21 -5.00% | -0.28 | 0.07 | 25.81% |
| Q3 2023 Q2Q % growth | -0.22 -10.00% | -0.29 | 0.07 | 24.32% |
| Q2 2023 Q2Q % growth | -0.25 -4.17% | -0.26 | 0.01 | 5.44% |
| Q1 2023 Q2Q % growth | -0.25 | -0.23 | -0.02 | -8.45% |
| Q4 2022 Q2Q % growth | -0.20 13.04% | -0.24 | 0.04 | 16.56% |
| Q3 2022 Q2Q % growth | -0.20 -17.65% | -0.27 | 0.07 | 25.73% |
| Q2 2022 Q2Q % growth | -0.24 -41.18% | -0.26 | 0.02 | 6.70% |
| Q1 2022 Q2Q % growth | -0.25 -78.57% | -0.24 | -0.01 | -6.10% |
| Q4 2021 Q2Q % growth | -0.23 -21.05% | -0.18 | -0.05 | -31.35% |
| Q3 2021 Q2Q % growth | -0.17 10.53% | -0.17 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.17 66.67% | -0.15 | -0.02 | -11.30% |
| Q1 2021 Q2Q % growth | -0.14 | -0.15 | 0.01 | 6.95% |
| Q4 2020 Q2Q % growth | -0.19 62.75% | -0.14 | -0.05 | -33.05% |
| Q3 2020 Q2Q % growth | -0.19 73.24% | -0.19 | 0.00 | 0.21% |
| Q2 2020 Q2Q % growth | -0.51 35.44% | -0.24 | -0.27 | -108.33% |
| Q4 2019 Q2Q % growth | -0.51 | -0.59 | 0.08 | 13.04% |
| Q3 2019 Q2Q % growth | -0.71 | -0.86 | 0.15 | 17.13% |
| Q2 2019 Q2Q % growth | -0.79 | -0.54 | -0.25 | -46.13% |
| Q1 2019 Q2Q % growth | -1.02 | -1.09 | 0.07 | 6.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 109K -46.83% | 98.359K | 10.641K | 10.82% |
| Q4 2024 Q2Q % growth | 151K -3.21% | 96.053K | 54.947K | 57.20% |
| Q3 2024 Q2Q % growth | 165K 17.02% | 81.6K | 83.4K | 102.21% |
| Q2 2024 Q2Q % growth | 163K 50.93% | 59.925K | 103.075K | 172.01% |
| Q1 2024 Q2Q % growth | 205K 146.99% | 56.1K | 148.9K | 265.42% |
| Q4 2023 Q2Q % growth | 156K 20.00% | 38.25K | 117.75K | 307.84% |
| Q3 2023 Q2Q % growth | 141K 56.67% | 51K | 90K | 176.47% |
| Q2 2023 Q2Q % growth | 108K 20.00% | 51K | 57K | 111.76% |
| Q1 2023 Q2Q % growth | 83K 18.57% | 56.712K | 26.288K | 46.35% |
| Q4 2022 Q2Q % growth | 130K | 74.715K | 55.285K | 73.99% |
| Q3 2022 Q2Q % growth | 90K | 69.564K | 20.436K | 29.38% |
| Q2 2022 Q2Q % growth | 90K 28.57% | 66.096K | 23.904K | 36.17% |
| Q1 2022 Q2Q % growth | 70K | 48.113K | 21.887K | 45.49% |
| Q4 2021 Q2Q % growth | 130K 8.33% | 43.35K | 86.65K | 199.88% |
| Q3 2021 Q2Q % growth | 90K -35.71% | 30.6K | 59.4K | 194.12% |
| Q2 2021 Q2Q % growth | 70K 75.00% | 155.55K | -85.55K | -55.00% |
| Q1 2021 Q2Q % growth | 70K | 155.55K | -85.55K | -55.00% |
| Q4 2020 Q2Q % growth | 120K 33.33% | 33.15K | 86.85K | 261.99% |
| Q3 2020 Q2Q % growth | 140K 180.00% | 33.997K | 106.003K | 311.81% |
| Q2 2020 Q2Q % growth | 40K | 40K | % | |
| Q1 2020 Q2Q % growth | 70K 16.67% | % | ||
| Q4 2019 Q2Q % growth | 90K | 57.63K | 32.37K | 56.17% |
| Q2 2019 Q2Q % growth | 40K | 183.6K | -143.6K | -78.21% |
| Q1 2019 Q2Q % growth | 60K | 176.46K | -116.46K | -66.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.35% | 2.35% | 2.54% | -0.67% |
| Revenue | 6.25% | 41.67% | 1.65% | 20.2% |